Geode Capital Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Sell |
643,335
-687,658
| -52% | -$227K | ﹤0.01% | 3855 |
|
|
2025
Q1 | $415K | Buy |
1,330,993
+1,558
| +0.1% | +$486 | ﹤0.01% | 3612 |
|
|
2024
Q4 | $1.24M | Buy |
1,329,435
+12,105
| +0.9% | +$11.3K | ﹤0.01% | 3288 |
|
|
2024
Q3 | $1.55M | Buy |
1,317,330
+14,816
| +1% | +$17.5K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $1M | Buy |
1,302,514
+42,435
| +3% | +$32.6K | ﹤0.01% | 3305 |
|
|
2024
Q1 | $3.84M | Buy |
1,260,079
+27,156
| +2% | +$82.8K | ﹤0.01% | 2841 |
|
|
2023
Q4 | $3.97M | Buy |
1,232,923
+32,146
| +3% | +$104K | ﹤0.01% | 2825 |
|
|
2023
Q3 | $4.61M | Sell |
1,200,777
-12,308
| -1% | -$47.3K | ﹤0.01% | 2679 |
|
|
2023
Q2 | $3.98M | Buy |
1,213,085
+713,450
| +143% | +$2.34M | ﹤0.01% | 2814 |
|
|
2023
Q1 | $1.29M | Hold |
499,635
| – | – | ﹤0.01% | 3235 |
|
|
2022
Q4 | $929K | Buy |
499,635
+7,562
| +2% | +$14.1K | ﹤0.01% | 3377 |
|
|
2022
Q3 | $905K | Buy |
492,073
+3,637
| +0.7% | +$6.69K | ﹤0.01% | 3437 |
|
|
2022
Q2 | $1.05M | Sell |
488,436
-5,422
| -1% | -$11.7K | ﹤0.01% | 3398 |
|
|
2022
Q1 | $1.55M | Sell |
493,858
-80,003
| -14% | -$251K | ﹤0.01% | 3384 |
|
|
2021
Q4 | $1.84M | Buy |
573,861
+22,959
| +4% | +$73.7K | ﹤0.01% | 3403 |
|
|
2021
Q3 | $1.85M | Buy |
550,902
+100,378
| +22% | +$337K | ﹤0.01% | 3384 |
|
|
2021
Q2 | $1.76M | Sell |
450,524
-313,313
| -41% | -$1.22M | ﹤0.01% | 3321 |
|
|
2021
Q1 | $3.07M | Buy |
763,837
+192,103
| +34% | +$772K | ﹤0.01% | 3035 |
|
|
2020
Q4 | $1.32M | Buy |
571,734
+1,816
| +0.3% | +$4.19K | ﹤0.01% | 3274 |
|
|
2020
Q3 | $3.27M | Sell |
569,918
-17,840
| -3% | -$102K | ﹤0.01% | 2627 |
|
|
2020
Q2 | $4.33M | Buy |
587,758
+293,721
| +100% | +$2.16M | ﹤0.01% | 2420 |
|
|
2020
Q1 | $876K | Buy |
294,037
+6,108
| +2% | +$18.2K | ﹤0.01% | 3070 |
|
|
2019
Q4 | $1.19M | Buy |
287,929
+60,887
| +27% | +$252K | ﹤0.01% | 3218 |
|
|
2019
Q3 | $735K | Hold |
227,042
| – | – | ﹤0.01% | 3350 |
|
|
2019
Q2 | $420K | Buy |
227,042
+6,354
| +3% | +$11.8K | ﹤0.01% | 3529 |
|
|
2019
Q1 | $390K | Buy |
220,688
+124,823
| +130% | +$221K | ﹤0.01% | 3531 |
|
|
2018
Q4 | $231K | Buy |
95,865
+6,391
| +7% | +$15.4K | ﹤0.01% | 3627 |
|
|
2018
Q3 | $507K | Buy |
89,474
+12,186
| +16% | +$69.1K | ﹤0.01% | 3461 |
|
|
2018
Q2 | $602K | Buy |
77,288
+27,269
| +55% | +$212K | ﹤0.01% | 3373 |
|
|
2018
Q1 | $353K | Buy |
50,019
+16,070
| +47% | +$113K | ﹤0.01% | 3519 |
|
|
2017
Q4 | $335K | Buy |
33,949
+50
| +0.1% | +$493 | ﹤0.01% | 3500 |
|
|
2017
Q3 | $290K | Buy |
33,899
+6,057
| +22% | +$51.8K | ﹤0.01% | 3539 |
|
|
2017
Q2 | $292K | Buy |
+27,842
| New | +$292K | ﹤0.01% | 3550 |
|